References
Carter JD, Valeriano J, Vasey FB (2003) Crohn disease worsened by Anakinra administration. J Clin Rheumatol 9(4):276–277
Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997) Increased serum Il-6 and Il-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9(11):853–858
Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R (1995) Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 36(1–2):29–36
Milaneschi Y, Corsi A, Penninx B, Bandinelli S, Guralnik J, Ferrucci L (2009) Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: The InCHIANTI study. Biol Psychiatry 65(11):973–978
Myint AM, Kim YK (2003) Cytokine-serotonin interactions through indoleamine 2, 3-dixygenase: a neurodegenerative hypothesis of depression. Med Hypoth 61(5–6):519–525
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jonville-Bera, A.P., Guilmot, JL., Aspe, G. et al. Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression?. Eur J Clin Pharmacol 67, 213–214 (2011). https://doi.org/10.1007/s00228-010-0915-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-010-0915-1